Search company, investor...

Predict your next investment

Corporation
RETAIL (NON-INTERNET/MOBILE) | Grocery
jztey.com

Investments

16

Portfolio Exits

2

Partners & Customers

5

About Jointown Pharmaceutical Group

Jointown Pharmaceutical (SHA: 600998) is a pharmaceutical wholesaler and distributor in China.

Headquarters Location

No.8 Longyang Road Hanyang District

Wuhan, Hubei, 430051,

China

4001600998

Want to inform investors similar to Jointown Pharmaceutical Group about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Jointown Pharmaceutical Group News

Kuehne + Nagel International : +Nagel forms strategic partnership with Chinese pharma specialist Jointown

Feb 24, 2021

02/24/2021 | 12:48am EST Message : Extensive cooperation across warehousing, domestic distribution, international transports and logistics In support of Chinese pharma customers' access to international markets, leveraging Kuehne+Nagel's global pharma network Further strengthens Kuehne+Nagel's presence in China Kuehne+Nagel announces a strategic partnership with Jointown, China's largest non-state-owned pharmaceutical distribution company, to accelerate its footprint in pharma and healthcare logistics in China. As one of the leading logistics providers in the world, Kuehne+Nagel has been especially focused on developing pharma & healthcare expertise for the past decade. The partnership with Jointown now affords access to their fullyGxP-compliant, in-country storage and distribution network, enabling Kuehne+Nagel to comply with the highly-regulated Chinese pharma & healthcare sector. 'We are pleased to be partnering with Jointown. Our cooperationperfectly meets the demands of our global clientele byenablingseamless supply chain coverage connecting China. This will enable us to accelerate our growth in the pharma and healthcare sector in China,' says Siewloong Wong, President of Kuehne+Nagel Asia Pacific. Zhang Qingsong, General Manager of the logistics business unit of Jointown Pharmaceutical Group, adds: 'Partnering with Kuehne+Nagel will provide Jointown's customers access to the international market through their global GxP certified air, sea and overseas contract logistics operations. We will now be able to expand our business in overseas markets at a much faster pace and benefit from the partnership in a sustainable way.' With Covid-19 vaccines becoming widely approved for use in more countries, Jointown and Kuehne+Nagel will collaborate to manage vaccine distribution in a safe and timely manner, leveraging their respective strengths in vaccine storage and distribution both in China and other parts of the world. Gianfranco Sgro, Member of the Management Board of Kuehne + Nagel International AG, responsible for Contract Logistics, says: 'Pharma & Healthcare is one of the fastest growing sectors in Contract Logistics. Kuehne+Nagel and Jointown share a common vision of service excellence for patients and customers in China and abroad'. The partnership with Jointown comes shortly after Kuehne+Nagel announced that it has entered into a binding agreement to acquire the Chinese company Apex International Corporation , one of Asia's leading freight forwarders. Latest news About Kuehne+Nagel With over 78,000 employees at 1,400 locations in over 100 countries, the Kuehne+Nagel Group is one of the world's leading logistics companies. Its strong market position lies in sea logistics, air logistics, road logistics and contract logistics, with a clear focus on integrated logistics solutions. About Jointown Jointown Pharmaceutical Group Co., Ltd. is a leading pharmaceutical company in China. Listed on the Shanghai Stock Exchange, Jointown is mainly responsible for supplying pharmaceutical drugs, traditional Chinese medicine (TCM), medical devices and consumer goods to clients including hospitals and clinics, retail pharmacies, wholesalers and government contracts. At the same time, Jointown provides e-commerce and online health management services to end users. Jointown Logistics, an affiliate of Jointown Pharmaceutical Group is a technology-based and environmentally-friendly logistics provider dedicated to serve the health industry. It provides customers with a wide range of integrated supply chain solutions supported by an extensive distribution network and advanced information technology capabilities. Attachments

Jointown Pharmaceutical Group Investments

16 Investments

Jointown Pharmaceutical Group has made 16 investments. Their latest investment was in Convalife as part of their Series B on January 1, 2023.

CBI Logo

Jointown Pharmaceutical Group Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/3/2023

Series B

Convalife

Yes

1

12/27/2022

Series D

First Bioscience

Yes

7/11/2022

Seed - II

Poclight Biological

$14.9M

Yes

Huatai Zijin Investment, Jointown Pharmaceutical Group, Nanjing New Industry Investment Group, and Wenzhou Investment

1

6/9/2022

Series B - II

Subscribe to see more

$99M

Subscribe to see more

10

4/19/2022

Series B - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/3/2023

12/27/2022

7/11/2022

6/9/2022

4/19/2022

Round

Series B

Series D

Seed - II

Series B - II

Series B - II

Company

Convalife

First Bioscience

Poclight Biological

Subscribe to see more

Subscribe to see more

Amount

$14.9M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Huatai Zijin Investment, Jointown Pharmaceutical Group, Nanjing New Industry Investment Group, and Wenzhou Investment

Sources

1

1

10

10

Jointown Pharmaceutical Group Portfolio Exits

2 Portfolio Exits

Jointown Pharmaceutical Group has 2 portfolio exits. Their latest portfolio exit was Zhongke Tongda on July 13, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/13/2021

IPO - II

$99M

Public

1

9/11/2014

Spinoff / Spinout

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/13/2021

9/11/2014

Exit

IPO - II

Spinoff / Spinout

Companies

Subscribe to see more

Valuation

$99M

$99M

Acquirer

Public

Subscribe to see more

Sources

1

10

Jointown Pharmaceutical Group Partners & Customers

5 Partners and customers

Jointown Pharmaceutical Group has 5 strategic partners and customers. Jointown Pharmaceutical Group recently partnered with Nippon Express on January 1, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

1/22/2021

Partner

Japan

Nippon Express (China) Inks MOU on Logistics Business Partnership with Jointown Pharmaceutical Group Logistics

This business partnership will allow Nippon Express to offer services that meet customer needs for safety-conscious pharmaceutical transport by combining its own pharmaceutical logistics services utilizing its global network outside China with JPG 's domestic transport network within China .

2

8/28/2018

Partner

China

Subscribe to see more

Subscribe to see more

10

8/28/2018

Partner

China

Subscribe to see more

Subscribe to see more

10

3/10/2016

Partner

China

Subscribe to see more

Subscribe to see more

0

1/11/2011

Partner

Japan

Subscribe to see more

Subscribe to see more

10

Date

1/22/2021

8/28/2018

8/28/2018

3/10/2016

1/11/2011

Type

Partner

Partner

Partner

Partner

Partner

Business Partner

Country

Japan

China

China

China

Japan

News Snippet

Nippon Express (China) Inks MOU on Logistics Business Partnership with Jointown Pharmaceutical Group Logistics

This business partnership will allow Nippon Express to offer services that meet customer needs for safety-conscious pharmaceutical transport by combining its own pharmaceutical logistics services utilizing its global network outside China with JPG 's domestic transport network within China .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

0

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.